Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» elamipretide
elamipretide
FDA Agrees to Meet with Stealth on Barth Syndrome Drug
BioSpace
Tue, 06/14/22 - 11:20 am
Stealth BioTherapeutics
FDA
Barth Syndrome
elamipretide
FDA shoots down a biotech’s last-stand patient pitch after faulting data
Endpoints
Wed, 10/20/21 - 10:29 am
Stealth BioTherapeutics
FDA
Barth Syndrome
elamipretide
The FDA wants more data. Stealth is filing for approval anyway
Fierce Biotech
Tue, 08/24/21 - 10:45 am
Stealth BioTherapeutics
elamipretide
FDA
clinical trials
Barth Syndrome
Stealth Bio Faces Setback in Failed Mitochondrial Disease Trial
BioSpace
Fri, 12/20/19 - 08:16 pm
Stealth BioTherapeutics
elamipretide
mitochondrial myopathy
clinical trials
Alexion bags option on Stealth's phase 3 rare disease drug
Fierce Biotech
Thu, 10/10/19 - 07:58 pm
Alexion
Stealth BioTherapeutics
clinical trials
mitochondrial myopathy
elamipretide